MSMohammad Reza Sharif

Mohammad Reza Sharif

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammad Reza Sharif has a total of 144 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Short term synbiotic supplementation improves hepatic and metabolic outcomes in children with metabolic dysfunction associated steatotic liver disease

    by Maryam Naseri Taheri, Abbas Taghaviardakani, Reza Hosseiniara, Javid Azadbakht, Mohammad Reza Sharif, Davood Kheirkhah

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasingly recognized chronic liver disorder in children and adolescents, particularly among those with obesity and insulin resistance. Given the emerging role of the gut–liver axis in disease pathogenesis, this study aimed to evaluate the effectiveness of synbiotic supplementation in improving biochemical and ultrasonographic outcomes in pediatric MASLD. This double-blind, randomized, placebo-controlled clinical trial was conducted over 8 weeks. A total of 60 participants aged 10–18 years with MASLD were randomly assigned to receive either synbiotics ( n = 30) or placebo ( n = 30). The synbiotic formulation contained a combination of nine probiotic strains with a prebiotic component, whereas the placebo consisted of prebiotic-only capsules (fructooligosaccharide with sucrose). The primary outcomes were predefined as changes in liver enzyme activities (alanine aminotransferase [ALT] and aspartate aminotransferase [AST]) and hepatic steatosis grade assessed by ultrasonography, while secondary outcomes included body mass index (BMI) and lipid profile parameters. Between-group differences were analyzed using appropriate statistical models adjusting for baseline values. After 8 weeks, the synbiotics group showed statistically significant reductions in BMI (− 0.70 ± 0.16 kg/m 2 ), triglycerides (− 10.50 ± 3.10 mg/dL), total cholesterol (− 10.50 ± 2.90 mg/dL), and LDL-cholesterol (− 5.46 ± 1.85 mg/dL) compared with the placebo group (all p < 0.001). Liver enzyme activities decreased significantly in the synbiotics group (ALT − 20.36 ± 7.18 U/L; AST − 16.76 ± 10.67 U/L), with greater reductions than in the placebo group ( p < 0.001 for between-group comparisons). Furthermore, improvement in hepatic steatosis grade was observed in 73.3% of participants in the synbiotics group compared to 23.3% in the placebo group ( p < 0.001). Synbiotic supplementation over an 8-week period was associated with significant improvements in liver enzyme activities, lipid profile, BMI, and ultrasonographic steatosis grade in children with MASLD. While these findings suggest a beneficial role for synbiotics as an adjunctive strategy, the relatively short intervention period and lack of control for lifestyle factors warrant cautious interpretation. Further studies with longer follow-up, detailed lifestyle assessment, and mechanistic investigations are needed to confirm these results and clarify the underlying pathways. Iranian Registry of Clinical Trials code : IRCT20220314054279N1.

  • Open Access

    Patients’ Attitudes Towards Bedside Teaching in Iran

    by Soleiman Ahmady, Mostafa Haji Rezaei, Mohammadreza Sharif, Davood Khairkhah, Mohammad Mahdi Heidari

    Background: Bedside teaching (BST) is a crucial component of the clinical skills training program for medical students, where patients are used as educational examples. Understanding patients’ attitudes toward BST is essential for making informed choices and enhancing quality. Objectives: The present study aimed to investigate the attitudes of hospitalized patients toward various aspects of BST. Methods: A cross-sectional study was coanducted involving 250 patients admitted to Shahid Beheshti Hospital in Kashan, Iran. Patients’ attitudes toward BST and influencing factors were assessed using a translated and validated version of the Marwan Questionnaire. Results: The highest level of dissatisfaction was observed with diagnostic or therapeutic procedures performed without the supervising professor (19.4%), while the lowest dissatisfaction was with students reviewing medical records (5.1%). Women expressed significantly more dissatisfaction than men regarding examinations conducted without a teacher and diagnostic and therapeutic procedures, both with and without a teacher present. Conversely, men were more opposed to students’ presence in outpatient clinics (23.8% vs. 5.4%, P < 0.001) and during surgeries (12.7% vs. 4.5%, P = 0.04) compared to women. Conclusions: Overall, patients generally accept the presence of students, irrespective of gender, and the presence of a supervising professor enhances patients’ willingness to participate in BST.


  • Open Access

    Curosurf Versus BLES in the Treatment of Preterm Neonates with Respiratory Distress Syndrome: A Randomized Clinical Trial

    by Vahidreza Ostadmohammadi, Mohammad Javad Namazi, Mahsa Rezasoltani, Mohammadreza Sharif, Farzaneh Sharifi, Ahmad Safari, Alireza Sharif

    Background: Two natural surfactants, Curosurf and BLES, are commonly used for the treatment of respiratory distress syndrome (RDS). Animal-derived surfactants have different pharmacological and biochemical features, and these differences might influence their clinical efficacy and complications. Objectives: The present study aimed to compare the clinical effectiveness and complications of Curosurf and BLES in the management of preterm neonates with RDS. Methods: This randomized clinical trial was conducted on 160 neonates with RDS and a gestational age of ≤ 32 weeks. Patients were randomly assigned to two intervention groups to receive either Curosurf (n = 80) or BLES (n = 80). Complications of prematurity, mortality, and the effectiveness of surfactant therapy were compared between the study groups. Results: There were statistically significant differences between the Curosurf group and the BLES group in the length of hospital stay (20.3 ± 14.4 vs. 27.3 ± 18.8 days, P = 0.01), number of surfactant injections (1.2 ± 0.4 vs. 1.4 ± 0.4, P = 0.006), and need for a second dose (21.2% vs. 41.2%, P = 0.005). In terms of complications, both groups showed no considerable differences. Conclusions: Compared to BLES, Curosurf may be more effective in the treatment of preterm neonates with RDS. Further clinical trials with robust designs and long-term follow-up are needed to compare these surfactants.


  • Wound Debridement in Pyoderma Gangrenosum

    by Arash Taheri, Parisa Mansoori, Mohammad Dpm Sharif

    BACKGROUND: Wound debridement improves healing in a variety of acute and chronic ulcers. However, there is concern that debridement may trigger pathergy and worsen pyoderma gangrenosum (PG). OBJECTIVE: To determine whether published evidence supports conservative wound debridement for PG. DATA SOURCES: The authors reviewed the literature published in MEDLINE through January 2023 using the search germs “pyoderma gangrenosum” and “debridement.” STUDY SELECTION: Articles reporting sharp surgical debridement or maggot debridement for PG were included in the review. The authors also searched the reference sections of the reviewed articles for additional reports on debridement for PG. DATA EXTRACTION: Clinical data regarding patient status, procedures performed, and patient outcomes were extracted from the selected articles. DATA SYNTHESIS: There are multiple reports of uncontrolled, active-phase PG wounds worsening after aggressive excisional debridement of viable inflamed tissues. In contrast, there is no evidence indicating that conservative debridement of nonviable necrotic tissue worsens PG wounds, regardless of the disease activity. There are multiple reports of successful debridement and surgical grafting for PG in remission. CONCLUSIONS: There is no evidence in favor of or against using conservative debridement of nonviable necrotic tissue for a PG wound. Therefore, it should not be considered contraindicated, even in the active phase of the disease.


  • Effects of Zinc Supplementation on Inflammatory Status and Nonalcoholic Steatohepatitis in Overweight or Obese Children: a Randomized Clinical Trial

    by Vahidreza Ostadmohammadi, Mohammad Javad Namazi, Mahsa Rezasoltani, Davood Kheirkhah, Mohammad Rajabi, Alireza Sharif, Abbas Taghavi Ardakani, Fariba Raygan, Amelia A. Assareh, Mohammad Reza Sharif

    The purpose of the present clinical trial was to determine the impact of zinc supplementation on serum liver enzymes, steatosis severity, lipid profile, and inflammatory status in overweight or obese children with nonalcoholic steatohepatitis (NASH). This randomized controlled trial was conducted by enrolling 60 children with NASH, aged 10–18 years old. The participants were randomly assigned to two groups that received either 30 mg/day of elemental zinc or placebo for 16 weeks. The severity of liver steatosis was evaluated using liver ultrasonography. Fasting blood samples were collected from each patient at the beginning and after 16 weeks of intervention to measure biochemical parameters. Following a 16-week intervention, zinc supplementation compared with placebo significantly decreased serum alanine aminotransferase (ALT) concentrations and high-sensitivity C-reactive protein and considerably enhanced HDL-cholesterol values. However, zinc intake had no considerable impact on aspartate aminotransferase, the severity of liver steatosis, anthropometric parameters, and other lipid indices versus the placebo group. Overall, zinc supplementation showed a promising impact on serum ALT, HDL-cholesterol, and inflammatory status in overweight or obese children suffering from NASH. Zinc supplementation may be a new strategy for the amelioration of NASH in overweight or obese children. This trial has been registered on the Iranian website for registration of clinical trials with the special ID of IRCT20200531047614N1 (https://www.irct.ir/trial/48543).


  • Open Access

    Prevalence of Vancomycin-Resistant Enterococcus in a Teaching Hospital in Kashan, Iran

    by Sahar Sattar, Davood Kheirkhah, Alireza Sharif, Mohammadjavad Azadchehr, Sareh Bagheri-Josheghani, Mohammad Reza Sharif

    Background: Enterococci bacteria are part of the intestinal microbial flora of humans and animals. However, the widespread use of antibiotics causes antibiotic resistance among these bacteria, making it necessary to identify effective antimicrobial agents against them. Objectives: This study aimed to investigate the phenotypic prevalence of vancomycin-resistant enterococci (VRE) in the clinical samples of patients admitted to Beheshti hospital in Kashan. Materials and Methods: This cross-sectional descriptive study was performed on 110 enterococci isolated from the clinical samples of hospitalized patients during 2017-2018. Vancomycin-resistant cases were identified and recorded after recording clinical and demographic information. Finally, the groups were statistically compared using chi-square and Fisher’s exact tests. Results: The present study findings demonstrated that the prevalence of VRE was 37.3%. There was a significant association between the prevalence of VRE and older age, diabetes, history of antibiotic use, and more extended hospital stays. Conversely, no significant relationship was found between VRE prevalence and gender, blood pressure, heart disease, year of sampling, and type of clinical sample. Conclusion: Overall, the incidence of vancomycin resistance in enterococci is increasing, which can be reduced by identifying effective antimicrobial agents and providing appropriate training to the medical staff and the general public.


  • Open Access

    The Effects of Probiotics Supplementation on Clinical Status and Biomarkers of Oxidative Damage and Inflammation in Children with Brucellosis: A Randomized, Double-Blind, and Placebo-Controlled Trial

    by Noushin Zamani, Zeinab Ganjy, Mohammad Reza Sharif, Abbas Taghavi Ardakani, Davood Kheirkhah, Mansour Sayyah, Ali Azimi, Alireza Sharif

    Background. Increased levels of inflammatory cytokines and oxidative damage may play crucial roles in the pathogenesis of brucellosis. The purpose of this trial was to evaluate the impact of probiotics administration on clinical status and biomarkers of oxidative damage and inflammation in pediatric patients diagnosed with brucellosis. Methods. This randomized, double-blind, and placebo-controlled trial was performed by recruiting 40 patients, 8–15 years of age, who had been diagnosed with brucellosis. Study participants were randomly allocated into two groups to receive either probiotics supplement or placebo (n = 20 each group) for 8 weeks. Blood samples were collected at the onset and after 8 weeks of intervention to quantify biochemical parameters. Clinical status was examined by a pediatric infectious disease specialist. Results. Following 8-week intervention, probiotics supplementation substantially improved total antioxidant capacity ( ) and malondialdehyde ( ). Furthermore, the difference between probiotics group and placebo group for the duration of fever ( ) and musculoskeletal pain ( ) was statistically significant, though probiotics administration had no significant effects on high-sensitivity C-reactive protein, total glutathione, and other clinical outcomes compared with placebo. Conclusion. Overall, probiotics intake had beneficial impact on clinical status and body antioxidative defense system in pediatric patients with brucellosis.


  • Open Access

    Association of 25-hydroxy vitamin D with asthma and its severity in children: a case–control study

    by Alireza Sharif, Hamed Haddad Kashani, Mohammad Reza Sharif

    Background: Universally, asthma has high prevalence rates and this has led numerous studies done into its causes. Despite extensive study on asthma the association between 25-Hydroxy Vitamin D (25(OH) vit. D) and asthma remains uncertain. In this study, the associations of 25(OH) vit. D levels with asthma and with the severity of asthma were evaluated. Methods: This was a case–control study performed in 2015 in the city of Isfahan. In this study 520 children were studied. Children with asthma were classified as cases and children who were referred for reasons other than respiratory problems and asthma were considered as controls. Serum 25 (OH) vit. D levels were then examined and compared between the two groups. Differences among groups were stated to be statistically significant when P-values < 0.05. Results: There were 260 asthmatic children and 260 controls in the present study. The mean 25 (OH) vit. D levels in the case group was 25.5 ± 16.62 and 16.76 ± 31.40 the control group and this difference was statistically significant (P < 0.05). 25(OH) vit. D levels were found to be 28.05 ± 16.98 in non-severe asthma and 21.41 ± 15.20 in severe asthma. Consequently 25(OH) vit. D level had inverse relationship with asthma severity (P = 0.002). Conclusions: As the results of this study showed, the lower level of 25(OH) vit. D correlated with the higher severity of asthma manifestations. Therefore, it is recommended that 25(OH) vit. D levels get routinely checked especially in severe asthma cases and if the deficiency presents, appropriate therapeutic measures be used to reduce the asthma severity.


  • The Role of Probiotics in the Treatment of Dysentery: a Randomized Double-Blind Clinical Trial

    by Alireza Sharif, Hamed Haddad Kashani, Elahe Nasri, Zahra Soleimani, Mohammad Reza Sharif

    Diarrhea is considered as an important cause of morbidity and mortality, even though one of the main reasons of death following diarrhea is initiated by dysentery. In recent years, the consumption of probiotics has been proposed for the treatment of infectious diarrhea. Despite most of the studies on probiotics have focused on acute watery diarrhea, few studies in the field of dysentery have found beneficial effects of probiotics. This study is a randomized double-blind clinical trial. The patients were randomly placed into control and case groups. In the intervention group, the patients received probiotics in the form of Kidilact® sachet, which contained high amounts of 7-strain friendly bacteria strains of Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus bulgaricus, Bifidobacterium infantis, Bifidobacterium breve, and Streptococcus thermophiles. On the other hand, the patients in the control group received placebo sachets on a daily basis for 5 days. It is notable that the treatment protocol of acute dysentery was done on both groups. The results of this study showed significant differences in the duration of blood in diarrhea between probiotic consumers (2.62 days) and the control group (3.16 days) (P value = 0.05). Additionally, significant differences in the average length of hospitalization in probiotic consumers (3.16 days) and control (3.66 days), (P value = 0.02) could be claimed that the consumption of probiotics is effective in reducing the duration of dysentery and diarrhea. The results of this study suggest that the use of probiotics can be effective in reducing the duration of blood in diarrhea. This study was also recorded in the Iran center of clinical trials registration database (IRCT2014060617985N1).